|
Healthy controls (n = 30)
|
Phase
|
Silent infection (n = 30)
|
Minor infection (n = 27)
|
Severe infection (n = 34)
|
P-value
|
---|
WBC, 10
9
/L
|
5.18 ± 1.21
|
AP
|
6.03 ± 1.13
|
5.49 ± 1.58
|
6.21 ± 2.96
|
0.1333
|
CP
|
6.17 ± 1.32b
|
ND
|
5.78 ± 1.40
|
0.0164a
|
Neutrophil, fraction
|
0.57 ± 0.08
|
AP
|
0.51 ± 0.09
|
0.51 ± 0.14
|
0.61 ± 0.15c,d
|
0.0020a
|
CP
|
0.52 ± 0.08
|
ND
|
0.50 ± 0.09b,e
|
0.0026a
|
Lymphocyte, fraction
|
0.34 ± 0.07
|
AP
|
0.38 ± 0.08
|
0.34 ± 0.15
|
0.27 ± 0.13c
|
0.0009a
|
CP
|
0.36 ± 0.08
|
ND
|
0.39 ± 0.08e
|
0.0609
|
Monocyte, fraction
|
0.07 ± 0.02
|
AP
|
0.09 ± 0.02
|
0.13 ± 0.03b,c
|
0.11 ± 0.04b,c
|
<0.0001a
|
CP
|
0.09 ± 0.02
|
ND
|
0.09 ± 0.02e
|
0.0001a
|
PLT, 10
9
/L
|
207.13 ± 36.88
|
AP
|
260.40 ± 54.22b
|
213.81 ± 47.54c
|
181.47 ± 48.33c
|
<0.0001a
|
| |
CP
|
224.37 ± 39.78e
|
ND
|
253.00 ± 51.70b,c,e
|
0.0004a
|
- AP, acute phase; CP, convalescent phase; ND, not determined; WBC, white blood cells; PLT, platelet.
-
asignificant differences in the four groups by one-way ANOVA.
-
bsignificant difference from the healthy control group.
-
csignificant difference from the silent infection group.
-
dsignificant difference from the minor infection group.
-
esignificant difference from the AP phase within a group.